Cargando…

Lipid droplets and autophagosomes together with chaperones fine‐tune expression of SGK1

Serum‐glucocorticoid‐induced kinase‐1 (SGK1) regulates ion homeostasis and promotes survival under stress conditions. The expression of SGK1 is under transcriptional and post‐translational regulations that are frequently altered in cancer and immune disorders. We report that an N‐terminal amphipathi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghani, Madiha J., Gu, Wenxue, Chen, Zhuyuan, Canessa, Cecilia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097849/
https://www.ncbi.nlm.nih.gov/pubmed/35393773
http://dx.doi.org/10.1111/jcmm.17300
_version_ 1784706255401517056
author Ghani, Madiha J.
Gu, Wenxue
Chen, Zhuyuan
Canessa, Cecilia M.
author_facet Ghani, Madiha J.
Gu, Wenxue
Chen, Zhuyuan
Canessa, Cecilia M.
author_sort Ghani, Madiha J.
collection PubMed
description Serum‐glucocorticoid‐induced kinase‐1 (SGK1) regulates ion homeostasis and promotes survival under stress conditions. The expression of SGK1 is under transcriptional and post‐translational regulations that are frequently altered in cancer and immune disorders. We report that an N‐terminal amphipathic alpha‐helix determines SGK1 expression levels through two distinct mechanisms. It tethers SGK1 to intracellular organelles generating a large pool of membrane‐bound SGK1, which is differentially stabilized in lipid droplets (LD) in fed conditions or degraded in the endoplasmic reticulum by ER‐phagy in starvation. Association of the α‐helix to organelles does not depend on dedicated receptors or special phospholipids rather, it is intrinsic to its physicochemical properties and depends on the presence of bulky hydrophobic residues for attachment to LDs. The second mechanism is recruitment of protein‐chaperones that recognize the α‐helix as an unfolded protein promoting survival of the cytosolic SGK1 fraction. Together, the findings unveil an unexpected link between levels of energy storage and abundance of SGK1 and how changes in calorie intake could be used to modulate SGK1 expression, whereas the inhibition of molecular chaperones could serve as an additional enhancer in the treatment of malignancies and autoimmune disorders with high levels of SGK1 expression.
format Online
Article
Text
id pubmed-9097849
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90978492022-05-18 Lipid droplets and autophagosomes together with chaperones fine‐tune expression of SGK1 Ghani, Madiha J. Gu, Wenxue Chen, Zhuyuan Canessa, Cecilia M. J Cell Mol Med Original Articles Serum‐glucocorticoid‐induced kinase‐1 (SGK1) regulates ion homeostasis and promotes survival under stress conditions. The expression of SGK1 is under transcriptional and post‐translational regulations that are frequently altered in cancer and immune disorders. We report that an N‐terminal amphipathic alpha‐helix determines SGK1 expression levels through two distinct mechanisms. It tethers SGK1 to intracellular organelles generating a large pool of membrane‐bound SGK1, which is differentially stabilized in lipid droplets (LD) in fed conditions or degraded in the endoplasmic reticulum by ER‐phagy in starvation. Association of the α‐helix to organelles does not depend on dedicated receptors or special phospholipids rather, it is intrinsic to its physicochemical properties and depends on the presence of bulky hydrophobic residues for attachment to LDs. The second mechanism is recruitment of protein‐chaperones that recognize the α‐helix as an unfolded protein promoting survival of the cytosolic SGK1 fraction. Together, the findings unveil an unexpected link between levels of energy storage and abundance of SGK1 and how changes in calorie intake could be used to modulate SGK1 expression, whereas the inhibition of molecular chaperones could serve as an additional enhancer in the treatment of malignancies and autoimmune disorders with high levels of SGK1 expression. John Wiley and Sons Inc. 2022-04-08 2022-05 /pmc/articles/PMC9097849/ /pubmed/35393773 http://dx.doi.org/10.1111/jcmm.17300 Text en © 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Ghani, Madiha J.
Gu, Wenxue
Chen, Zhuyuan
Canessa, Cecilia M.
Lipid droplets and autophagosomes together with chaperones fine‐tune expression of SGK1
title Lipid droplets and autophagosomes together with chaperones fine‐tune expression of SGK1
title_full Lipid droplets and autophagosomes together with chaperones fine‐tune expression of SGK1
title_fullStr Lipid droplets and autophagosomes together with chaperones fine‐tune expression of SGK1
title_full_unstemmed Lipid droplets and autophagosomes together with chaperones fine‐tune expression of SGK1
title_short Lipid droplets and autophagosomes together with chaperones fine‐tune expression of SGK1
title_sort lipid droplets and autophagosomes together with chaperones fine‐tune expression of sgk1
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097849/
https://www.ncbi.nlm.nih.gov/pubmed/35393773
http://dx.doi.org/10.1111/jcmm.17300
work_keys_str_mv AT ghanimadihaj lipiddropletsandautophagosomestogetherwithchaperonesfinetuneexpressionofsgk1
AT guwenxue lipiddropletsandautophagosomestogetherwithchaperonesfinetuneexpressionofsgk1
AT chenzhuyuan lipiddropletsandautophagosomestogetherwithchaperonesfinetuneexpressionofsgk1
AT canessaceciliam lipiddropletsandautophagosomestogetherwithchaperonesfinetuneexpressionofsgk1